NCT05205265View on ClinicalTrials.gov

Rivet PVS Therapy in Group 2 PH-HFpEF

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 10, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Heart FailurePulmonary Hypertension
Interventions
DEVICE

Rivet Shunt

The Rivet Shunt device will be implanted via a percutaneous, transcatheter approach

Trial Locations (3)

22908

UVA Cardiology Research, Charlottesville

55905

Mayo Clinic, Rochester

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

NXT Biomedical
All Listed Sponsors
lead

NXT Biomedical

INDUSTRY